TABLE 2.
The KEGG pathway analysis of DEGs ranked by count.
| Term | Count | Genes | P-value |
| KEGG_PATHWAY | |||
| hsa04062:Chemokine signaling pathway | 9 | SHC4, CCL8, CXCL8, PPBP, CCL19, CXCL13, CCL18, CXCL5, and CXCL16 | 2.12E-04 |
| hsa04060:Cytokine-cytokine receptor interaction | 9 | CCL8, CXCL8, PPBP, CCL19, CXCL13, IL7R, CCL18, CXCL5, and CXCL16 | 0.001258766 |
| hsa04151:PI3K-Akt signaling pathway | 9 | RELN, IBSP, COL11A1, KIT, SPP1, TNC, COL6A6, THBS2, and IL7R | 0.010615579 |
| hsa04510:Focal adhesion | 8 | SHC4, RELN, IBSP, COL11A1, SPP1, TNC, COL6A6, and THBS2 | 0.002157992 |
| hsa04512:ECM-receptor interaction | 7 | RELN, IBSP, COL11A1, SPP1, TNC, COL6A6, and THBS2 | 1.09E-04 |
| hsa04974:Protein digestion and absorption | 6 | CPA3, COL11A1, COL10A1, COL6A6, ATP1A2, and SLC16A10 | 0.001034968 |
| hsa03320:PPAR signaling pathway | 5 | ACADL, MMP1, ADIPOQ, PLIN1, and PLTP | 0.002827573 |
| hsa04064:NF-kappa B signaling pathway | 5 | VCAM1, CXCL8, BCL2A1, PLAU, and CCL19 | 0.007200464 |
| hsa04650:Natural killer cell mediated cytotoxicity | 5 | SHC4, FCGR3A, FCGR3B, FCER1G, and GZMB | 0.022607194 |
| hsa05323:Rheumatoid arthritis | 4 | CXCL8, MMP1, ACP5, and CXCL5 | 0.042784539 |
| hsa00380:Tryptophan metabolism | 3 | TDO2, ALDH2, and MAOA | 0.048643268 |